Eli Lilly shares MDR-TB drug technology with Shasun Pharma – Livemint
0
“US drug maker Eli Lilly and Company said on Thursday that it had shared the manufacturing technology for two antibiotic drugs meant for the treatment of multi-drug resistant tuberculosis (MDR-TB) with India’s Shasun Pharmaceuticals Ltd as part of its ongoing programme to increase access of these medicines in countries including India, China, Russia and South Africa, where drug-resistant TB is most prevalent.”
From – Livemint